We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THR
576
DELISTED
Thermon Group Holdings
THR
| $1.39M | 0.01% |
55,877
+31,259
| +127% | +$763K |
|
577
Albemarle
ALB
$15.4B
| $1.39M | 0.01% |
6,291
-3,763
| -37% | -$927K |
|
578
Qfin Holdings
QFIN
$1.5B
| $1.37M | 0.01% |
70,874
-161,661
| -70% | -$3.39M |
|
579
Destination XL Group
DXLG
$33.2M
| $1.37M | 0.01% |
248,735
-92,492
| -27% | -$586K |
|
580
International Money Express
IMXI
$354M
| $1.37M | 0.01% |
53,091
-3,024
| -5% | -$73.4K |
|
|
VRTV
581
DELISTED
VERITIV CORPORATION
VRTV
| $1.36M | 0.01% |
10,098
-3,121
| -24% | -$400K |
|
|
PAMT
582
PAMT Corp
PAMT
$282M
| $1.36M | 0.01% |
47,518
-2,126
| -4% | -$60K |
|
583
NMI Holdings
NMIH
$3.4B
| $1.36M | 0.01% |
60,761
-3,923
| -6% | -$88K |
|
584
Esquire Financial Holdings
ESQ
$1.6B
| $1.36M | 0.01% |
34,656
-1,517
| -4% | -$63.9K |
|
585
BlackLine
BL
$1.7B
| $1.35M | 0.01% |
20,174
+12,461
| +162% | +$859K |
|
586
Sterling Infrastructure
STRL
$17B
| $1.35M | 0.01% |
35,759
-5,991
| -14% | -$219K |
|
587
Crocs
CROX
$6.29B
| $1.35M | 0.01% |
10,691
+5,906
| +123% | +$714K |
|
|
CIR
588
DELISTED
CIRCOR International, Inc
CIR
| $1.35M | 0.01% |
43,435
+23,785
| +121% | +$650K |
|
|
NAPA
589
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $1.34M | 0.01% |
+84,449
| New | +$1.33M |
|
|
X
590
DELISTED
US Steel
X
| $1.33M | 0.01% |
50,943
| – | – |
|
|
TRST
591
Trustco Bank Corp NY
TRST
$974M
| $1.32M | 0.01% |
41,243
-2,641
| -6% | -$94.7K |
|
592
Grab
GRAB
$14.8B
| $1.32M | 0.01% |
437,152
+3,102
| +0.7% | +$10.3K |
|
593
Charter Communications
CHTR
$18.4B
| $1.31M | 0.01% |
3,675
-43
| -1% | -$16.1K |
|
594
Darden Restaurants
DRI
$25.3B
| $1.31M | 0.01% |
+8,462
| New | +$1.25M |
|
595
United Parks & Resorts
PRKS
$2.05B
| $1.31M | 0.01% |
21,403
+17,084
| +396% | +$1.04M |
|
596
DMC Global
BOOM
$155M
| $1.31M | 0.01% |
+59,537
| New | +$1.36M |
|
597
Regional Management Corp
RM
$301M
| $1.3M | 0.01% |
49,842
-9,288
| -16% | -$288K |
|
598
Evertec
EVTC
$1.88B
| $1.29M | 0.01% |
+38,229
| New | +$1.34M |
|
599
Otter Tail
OTTR
$3.89B
| $1.29M | 0.01% |
17,787
-1,368
| -7% | -$90.9K |
|
600
Coastal Financial
CCB
$779M
| $1.28M | 0.01% |
35,435
-1,081
| -3% | -$46.6K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.